https://www.selleckchem.com/pr....oducts/leptomycinb.h
CA-STEMI had increased mortality rates (23.7% vs 16.1%, p less then 0.001) compared to CA without STEMI. On multivariate logistic regression analysis, coronary interventions including PCI (OR 0.6, CI 0.4-1.1; p = 0.3) and CABG (OR 0.7, CI 0.3-1.8; p = 0.2) had no association with mortality among CA patients. The absolute yearly trends for prevalence and mortality associated with STEMI in CA patients remained steady over the study years (linear p-trends 0.2 and 0.6, respectively).CA-STEMI is associated with significant complication
Curtir
Comentario
Compartilhar
